Cargando…
CXC chemokine receptor 1 predicts postoperative prognosis and chemotherapeutic benefits for TNM II and III resectable gastric cancer patients
BACKROUND: Abnormal expression of CXC chemokine receptor 1 (CXCR1) has shown the ability to promote tumor angiogensis, invasion and metastasis in several cancers. The purpose of our curret study is to discover the clinical prognostic significance of CXCR1 in resectable gastric cancer. METHODS: 330 g...
Autores principales: | Cao, Yifan, Liu, Hao, Zhang, Heng, Lin, Chao, Li, Ruochen, Wu, Songyang, Li, He, He, Hongyong, Zhang, Weijuan, Xu, Jiejie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386765/ https://www.ncbi.nlm.nih.gov/pubmed/27780937 http://dx.doi.org/10.18632/oncotarget.12815 |
Ejemplares similares
-
Glycoprotein 130 is associated with adverse postoperative clinical outcomes of patients with late-stage non-metastatic gastric cancer
por: Cao, Yifan, et al.
Publicado: (2016) -
Intratumoral PD-1(+)CD8(+) T cells associate poor clinical outcomes and adjuvant chemotherapeutic benefit in gastric cancer
por: Yu, Kuan, et al.
Publicado: (2022) -
High expression of C-C chemokine receptor 2 associates with poor overall survival in gastric cancer patients after surgical resection
por: Li, Ruochen, et al.
Publicado: (2016) -
The prognostic value of CXC-chemokine receptor 2 (CXCR2) in gastric cancer patients
por: Wang, Zhenglin, et al.
Publicado: (2015) -
The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors—A Review of Literature
por: Korbecki, Jan, et al.
Publicado: (2021)